Watch replay from 2021 NA Biotech Start-Up Symposium

The Role of the Virus-Like Particle (VLP) Vaccine Technology in the Evolving SARS-COV-2 Pandemic and its Unique Advantages in an Overcrowded Vaccine Field.

Speaker: Jose Galarza, DVM, PhD, TechnoVax. Inc.

This video is only available in the U.S. and Canada.

Fields indicated by an * are required.